Impax Asset Management Group plc boosted its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 216.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 410,000 shares of the industrial products company's stock after buying an additional 280,431 shares during the quarter. Impax Asset Management Group plc owned 1.01% of TriMas worth $10,467,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in TRS. Innealta Capital LLC purchased a new position in shares of TriMas in the second quarter valued at approximately $26,000. Quantbot Technologies LP boosted its stake in shares of TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company's stock valued at $239,000 after purchasing an additional 478 shares during the period. Aristides Capital LLC purchased a new position in shares of TriMas in the second quarter valued at approximately $245,000. Algert Global LLC boosted its stake in shares of TriMas by 4.2% in the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company's stock valued at $403,000 after purchasing an additional 639 shares during the period. Finally, Inspire Investing LLC lifted its stake in TriMas by 17.4% in the third quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company's stock worth $412,000 after acquiring an additional 2,389 shares during the last quarter. Hedge funds and other institutional investors own 99.42% of the company's stock.
TriMas Stock Up 4.4 %
TriMas stock traded up $1.16 during trading on Wednesday, reaching $27.34. The stock had a trading volume of 735,024 shares, compared to its average volume of 268,553. TriMas Co. has a 52-week low of $22.45 and a 52-week high of $28.51. The business has a 50 day moving average price of $25.86 and a 200 day moving average price of $25.82. The company has a quick ratio of 1.48, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. The stock has a market cap of $1.11 billion, a PE ratio of 43.59 and a beta of 0.66.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.23% and a net margin of 2.93%. The company had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. During the same period in the previous year, the business posted $0.57 EPS. The firm's revenue for the quarter was down 2.5% compared to the same quarter last year. On average, analysts predict that TriMas Co. will post 1.75 EPS for the current year.
TriMas Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th will be issued a dividend of $0.04 per share. The ex-dividend date is Tuesday, November 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.59%. TriMas's payout ratio is currently 25.00%.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on TRS shares. BWS Financial reiterated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Tuesday. StockNews.com downgraded shares of TriMas from a "hold" rating to a "sell" rating in a research note on Tuesday.
Get Our Latest Stock Report on TriMas
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.